Novartis keeps CEO pay steady, but incoming chairman pay drops
BASEL (Reuters) - Novartis kept pay for its Chief Executive Joe Jimenez steady, after cutting it last year before a Swiss vote to force companies to accept shareholder limits on executive rewards.
Related Articles
- AIG Chairman Steve Miller to Step Down in July also written by Reuters
- Six Years Later, The Problem at HP is Still the Board also categorized in BoardNews
- Germany's Corporate Governance Problem also categorized in BoardNews
- Getting Gen-Y on Boards (of Directors) also categorized in BoardNews
- Exclusive: IBM hired advisers to deal with restless investors - sources also written by Reuters
- Exclusive: Activist investor Sandell urges swap on DCP Midstream also published in Chicago Tribune
- A Changed and Changing Executive Compensation Environment also mentions Executive Compensation
- Taiwan Court Orders Reinstatement Of Two CPDC Board Candidates As Contested Vote Nears also categorized in BoardNews
- Lululemon Has A New CEO also written by Reuters
- Coca-Cola Faces Renewed Pressure Over Executive Pay also written by Reuters
Login to comment.